- Editorial
Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders
- Panagiotis Mallis,
- Efstathios Michalopoulos and
- Catherine Stavropoulos-Giokas
Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...]

